Cybin pushes forward with Phase 3 depression trials after narrowing its loss, while securing a $100M funding program. The post Cybin sees third-quarter loss on R&D costs, advances clinical programs appeared first on Green Market Report.

Many businesses are grappling with declining wholesale prices, compliance costs and limited access to banking. The post Businesses in receivership flood the market amid cannabis industry challenges appeared first on Green Market Report.

The success of Epidiolex prompted several companies to attempt to create generic versions. The post Jazz Pharmaceutical wraps up Epidiolex patent claims appeared first on Green Market Report.

The founders of cannabis edibles maker Hometown Hero are betting on luxury CBD skincare with their acquisition of Prima. The post CBD brand Prima acquired by Sky Marketing appeared first on Green Market Report.

Australia’s medical cannabis revenue is expected to grow from around $600 million (AU$955.1 million) in 2024 to more than $1.2 billion by 2028, according to a new report. Australia’s medical cannabis revenue may outpace top EU markets, report shows is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Winter is peak season for marijuana-infused chocolates, according to edibles manufacturers and Seattle-based cannabis data provider Headset. Marijuana-infused chocolate edibles experiencing seasonal sales spike is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs